Literature DB >> 10934208

Dephosphorylation of human cyclin-dependent kinases by protein phosphatase type 2C alpha and beta 2 isoforms.

A Cheng1, P Kaldis, M J Solomon.   

Abstract

We previously reported that the activating phosphorylation on cyclin-dependent kinases in yeast (Cdc28p) and in humans (Cdk2) is removed by type 2C protein phosphatases. In this study, we characterize this PP2C-like activity in HeLa cell extract and determine that it is due to PP2C beta 2, a novel PP2C beta isoform, and to PP2C alpha. PP2C alpha and PP2C beta 2 co-purified with Mg(2+)-dependent Cdk2/Cdk6 phosphatase activity in DEAE-Sepharose, Superdex-200, and Mono Q chromatographies. Moreover, purified recombinant PP2C alpha and PP2C beta 2 proteins efficiently dephosphorylated monomeric Cdk2/Cdk6 in vitro. The dephosphorylation of Cdk2 and Cdk6 by PP2C isoforms was inhibited by the binding of cyclins. We found that the PP2C-like activity in HeLa cell extract, partially purified HeLa PP2C alpha and PP2C beta 2 isoforms, and the recombinant PP2Cs exhibited a comparable substrate preference for a phosphothreonine containing substrate, consistent with the conservation of threonine residues at the site of activating phosphorylation in CDKs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10934208     DOI: 10.1074/jbc.M006210200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Protein phosphatase 2Cbetal regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells.

Authors:  Satyanarayana R Pondugula; Alexander A Tong; Jing Wu; Jimmy Cui; Taosheng Chen
Journal:  Drug Metab Dispos       Date:  2010-06-10       Impact factor: 3.922

2.  Plasmodium falciparum inhibitor-3 homolog increases protein phosphatase type 1 activity and is essential for parasitic survival.

Authors:  Aline Fréville; Isabelle Landrieu; M Adelaida García-Gimeno; Jérôme Vicogne; Muriel Montbarbon; Benjamin Bertin; Alexis Verger; Hadidjatou Kalamou; Pascual Sanz; Elisabeth Werkmeister; Christine Pierrot; Jamal Khalife
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

Review 3.  Type 2C protein phosphatases in fungi.

Authors:  Joaquín Ariño; Antonio Casamayor; Asier González
Journal:  Eukaryot Cell       Date:  2010-11-12

4.  Quantitative proteomics reveals novel protein interaction partners of PP2A catalytic subunit in pancreatic β-cells.

Authors:  Xiangmin Zhang; Divyasri Damacharla; Danjun Ma; Yue Qi; Rebecca Tagett; Sorin Draghici; Anjaneyulu Kowluru; Zhengping Yi
Journal:  Mol Cell Endocrinol       Date:  2016-01-09       Impact factor: 4.102

5.  Discovery of protein phosphatase 2C inhibitors by virtual screening.

Authors:  Jessica P Rogers; Albert E Beuscher; Marc Flajolet; Thomas McAvoy; Angus C Nairn; Arthur J Olson; Paul Greengard
Journal:  J Med Chem       Date:  2006-03-09       Impact factor: 7.446

6.  Evolution of the metazoan protein phosphatase 2C superfamily.

Authors:  Adi Stern; Eyal Privman; Michal Rasis; Sara Lavi; Tal Pupko
Journal:  J Mol Evol       Date:  2006-12-06       Impact factor: 2.395

7.  Protein tyrosine and serine-threonine phosphatases in the sea urchin, Strongylocentrotus purpuratus: identification and potential functions.

Authors:  C A Byrum; K D Walton; A J Robertson; S Carbonneau; R T Thomason; J A Coffman; D R McClay
Journal:  Dev Biol       Date:  2006-08-25       Impact factor: 3.582

8.  Mechanisms of checkpoint kinase Rad53 inactivation after a double-strand break in Saccharomyces cerevisiae.

Authors:  Ghislaine Guillemain; Emilie Ma; Sarah Mauger; Simona Miron; Robert Thai; Raphaël Guérois; Françoise Ochsenbein; Marie-Claude Marsolier-Kergoat
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

Review 9.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

10.  Inhibition of p21-activated kinase 6 (PAK6) increases radiosensitivity of prostate cancer cells.

Authors:  Min Zhang; Michael Siedow; Gregory Saia; Arnab Chakravarti
Journal:  Prostate       Date:  2010-06-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.